标题
STATs in NK-Cells: The Good, the Bad, and the Ugly
作者
关键词
-
出版物
Frontiers in Immunology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-01-18
DOI
10.3389/fimmu.2016.00694
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- STAT4-associated natural killer cell tolerance following liver transplantation
- (2016) K M Jamil et al. GUT
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models
- (2016) Alessia Bottos et al. Nature Communications
- STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
- (2016) D. Gotthardt et al. Cancer Discovery
- Regulation of Natural Killer Cell Function by STAT3
- (2016) Nicholas A. Cacalano Frontiers in Immunology
- Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicity
- (2016) Eva Maria Putz et al. OncoImmunology
- JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
- (2015) Kathrin Schönberg et al. CANCER RESEARCH
- JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
- (2015) L. Springuel et al. HAEMATOLOGICA
- Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes
- (2015) M. Hejazi et al. HAEMATOLOGICA
- Long-Term Follow-up of STAT5B Deficiency in Three Argentinian Patients: Clinical and Immunological Features
- (2015) Liliana Bezrodnik et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
- (2015) Alexandra Y. Kreins et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of tumor infiltrating natural killer cell subset
- (2015) Inbar Levi et al. Oncotarget
- JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
- (2015) L. Springuel et al. HAEMATOLOGICA
- Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes
- (2015) M. Hejazi et al. HAEMATOLOGICA
- In vivotumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
- (2015) Michaela Prchal-Murphy et al. OncoImmunology
- Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia
- (2015) Angelika Berger et al. Oncotarget
- The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
- (2015) Antonino Bruno et al. NEOPLASIA
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
- (2014) Kodappully Sivaraman Siveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation
- (2014) S. Zhu et al. BLOOD
- Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
- (2014) D. Gotthardt et al. BLOOD
- Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
- (2014) D. Mittal et al. CANCER RESEARCH
- IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness
- (2014) Andrea Ziblat et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Inborn errors of the development of human natural killer cells
- (2013) Emmanuelle Jouanguy et al. Current Opinion in Allergy and Clinical Immunology
- T cell regulation of natural killer cells
- (2013) Yann Kerdiles et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3
- (2013) C. Fionda et al. JOURNAL OF IMMUNOLOGY
- CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
- (2013) Eva Maria Putz et al. Cell Reports
- Epigenetic regulation of NK cell differentiation and effector functions
- (2013) Frank Cichocki et al. Frontiers in Immunology
- Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes
- (2012) Stephanie Boisson-Dupuis et al. CURRENT OPINION IN IMMUNOLOGY
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Proinflammatory cytokine signaling required for the generation of natural killer cell memory
- (2012) Joseph C. Sun et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance
- (2012) Rupsha Fraser et al. JOURNAL OF PATHOLOGY
- Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance
- (2012) Tatsuaki Mizutani et al. OncoImmunology
- Severe impairment of IFN- and IFN- responses in cells of a patient with a novel STAT1 splicing mutation
- (2011) D. Vairo et al. BLOOD
- Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
- (2011) R. Bedel et al. CANCER RESEARCH
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets
- (2011) Alice Laroni et al. PLoS One
- Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions
- (2011) D. Chakraborty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development
- (2010) E. Eckelhart et al. BLOOD
- Natural Killer Cell Education and Tolerance
- (2010) Mark T. Orr et al. CELL
- IL-7 Enhances Survival of Human CD56bright NK Cells
- (2010) Annie Michaud et al. JOURNAL OF IMMUNOTHERAPY
- Tumor-associated macrophages: Effectors of angiogenesis and tumor progression
- (2009) Seth B. Coffelt et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
- (2009) M. Matsui et al. CANCER RESEARCH
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease
- (2009) Zhanju Liu et al. INFLAMMATORY BOWEL DISEASES
- A partial form of recessive STAT1 deficiency in humans
- (2009) Ariane Chapgier et al. JOURNAL OF CLINICAL INVESTIGATION
- A Programmed Switch from IL-15- to IL-2-Dependent Activation in Human NK Cells
- (2009) Anne-Hélène Pillet et al. JOURNAL OF IMMUNOLOGY
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Role of Stat3 in suppressing anti-tumor immunity
- (2008) Marcin Kortylewski et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells
- (2008) L R Grant et al. GENES AND IMMUNITY
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- Canonical and non-canonical JAK–STAT signaling
- (2008) Willis X. Li TRENDS IN CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started